[go: up one dir, main page]

WO2000033956A1 - Alkene hydroformylation catalyst - Google Patents

Alkene hydroformylation catalyst Download PDF

Info

Publication number
WO2000033956A1
WO2000033956A1 PCT/GB1999/004062 GB9904062W WO0033956A1 WO 2000033956 A1 WO2000033956 A1 WO 2000033956A1 GB 9904062 W GB9904062 W GB 9904062W WO 0033956 A1 WO0033956 A1 WO 0033956A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
ligand
complex
catalyst
hydroformylation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1999/004062
Other languages
French (fr)
Inventor
David Cole-Hamilton
Douglas Foster
David Gudmunsen
Eric George Hope
Alison Marion Stuart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of St Andrews
Original Assignee
University of St Andrews
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9826619.0A external-priority patent/GB9826619D0/en
Priority claimed from GBGB9902338.4A external-priority patent/GB9902338D0/en
Application filed by University of St Andrews filed Critical University of St Andrews
Priority to AU15744/00A priority Critical patent/AU1574400A/en
Publication of WO2000033956A1 publication Critical patent/WO2000033956A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1845Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1845Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
    • B01J31/185Phosphites ((RO)3P), their isomeric phosphonates (R(RO)2P=O) and RO-substitution derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1845Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
    • B01J31/1865Phosphonites (RP(OR)2), their isomeric phosphinates (R2(RO)P=O) and RO-substitution derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0073Rhodium compounds
    • C07F15/008Rhodium compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/141Esters of phosphorous acids
    • C07F9/145Esters of phosphorous acids with hydroxyaryl compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/32Addition reactions to C=C or C-C triple bonds
    • B01J2231/321Hydroformylation, metalformylation, carbonylation or hydroaminomethylation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/822Rhodium
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/90Catalytic systems characterized by the solvent or solvent system used
    • B01J2531/94Fluorinated solvents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/90Catalytic systems characterized by the solvent or solvent system used
    • B01J2531/98Phase-transfer catalysis in a mixed solvent system containing at least 2 immiscible solvents or solvent phases
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2540/00Compositional aspects of coordination complexes or ligands in catalyst systems
    • B01J2540/20Non-coordinating groups comprising halogens
    • B01J2540/22Non-coordinating groups comprising halogens comprising fluorine, e.g. trifluoroacetate
    • B01J2540/225Non-coordinating groups comprising halogens comprising fluorine, e.g. trifluoroacetate comprising perfluoroalkyl groups or moieties
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2540/00Compositional aspects of coordination complexes or ligands in catalyst systems
    • B01J2540/60Groups characterized by their function
    • B01J2540/64Solubility enhancing groups

Definitions

  • the invention concerns an improved process for the hydroformylation of alkenes .
  • Hydroformylation is a major industrial process that involves the reaction of carbon monoxide and hydrogen with an alkene to give an aldehyde.
  • alkenes two products are possible depending upon the regioselectivity of the addition reaction.
  • the two products, linear (n) aldehyde and branched (i) aldehyde are generally obtained as a mixture but it is usually the linear product that is preferred for industrial applications.
  • the two reactions referred to above are both carried out in the homogeneous phase (i.e. the catalyst, substrate and products are all dissolved in a common solvent) and this means that a process is required for the separation of products, solvent and catalyst. Distillation is generally used, but the thermal sensitivity of the rhodium based catalysts means that they cannot be separated from longer chain aldehyde products (>C 4 ) .
  • One way of circumventing this problem is to use a two phase system with the catalyst dissolved in water. Since the substrate and products are immiscible in water, separation can be effected in a simple manner.
  • substrates with chain lengths of greater than 6 have such low solubility in water that the rate of the hydroformylation is too low for the aqueous process to be of commercial interest; and yet, it is just these substrates (C 9 -C 14 aldehydes) that are of interest for the production of soaps and detergents. Consequently the C 9 -C 14 aldehydes are currently manufactured using the older, less selective, more energy intensive cobalt based systems.
  • Desirable properties of such a system are that the reaction rate should be high (comparable to that with Rh/PPh 3 ) , that the rhodium content of the organic phase at the end of the reaction should be negligible and that the n:i ratio should be high, preferably using only a small amount of phosphine relative to rhodium.
  • EP-A-0, 633, 062 describes the use of [Rh(C0 2 ) (acetylacetonate) ] with either P [CH 2 CH 2 (CF 2 ) 5 CF 3 ] 3 or P[OCH 2 CH 2 (CF 2 ) 7 CF 3 ] 3 at a P:Rh ratio of 40:1.
  • the invention concerns new Iigands for use in the fiuorous biphasic hydroformylation of alkenes, which Iigands allow the reaction to occur at rates similar to those obtained using Rh/PPh 3 in organic solvents, which show little leaching of rhodium into the organic phase and which can provide high n:i ratios at low P:Rh loading.
  • the Iigands described herein also promote isomerisation of alkenes and can be used for the hydroformylation of internal alkenes giving significant amounts of n-aldehydes.
  • Iigands of general formula I when complexed to a rhodium centre are especially good at catalysis of alkene hydroformylation in a fiuorous multiphase system of the type described above.
  • the present invention provides a catalytic complex comprising a ligand of general formula I:
  • Ph is an optionally substituted phenyl ring; each group L independently represents a alkenyl group or other linker group;
  • each group Z represents a branched or linear fluorocarbon chain of up to 11 carbon atoms, preferably 3 to 9 carbon atoms ;
  • each group Y independently represents a group
  • each group Y may represent a C 1 -C 12 alkyl or aryl, which may optionally be substituted;
  • each a is 0 or 1;
  • each b is 0 or 1;
  • each m is an integer of from 1 to 5
  • said ligand is complexed directly or indirectly via the phosphorous moiety to a rhodium centre, for use in catalysis of hydroformylation of alkenes in a fiuorous multiphase system.
  • fiuorous multiphase system we mean a system including a liquid-liquid biphase where one phase is a fiuorous phase containing a fiuorous solvent (typically a fluorocarbon or a fluorohydrocarbon) .
  • a fiuorous solvent typically a fluorocarbon or a fluorohydrocarbon
  • Suitable solvents include fluorodimethylcyclohexane, perfluoromethylcyclohexane, hexafluorobenzene, pentafluorobenzene and the like.
  • the ligand of general formula I comprises a single fluorocarbon tail linked to a phenyl ring which is otherwise unsubstituted (apart from its connection to group X or to the phosphorous moiety) .
  • Group Z may represent a linear group -(CF 2 ) n - and n is an integer of from 3 to 11. Desirably integer n represents 3, 4, 5, 6, 7, 8 or 9. Generally Iigands where n represents 4, 5, 6 or 7 are most convenient.
  • the fluorocarbon tail (eg. -Z-CF 3 ) is required to adjust the solubility of the ligand in the fiuorous phase.
  • the exact number of fluorinated carbon atoms is not fixed, but may vary according to the reactants, solvents and other reaction conditions. If a single -Z-CF 3 tail is present, it may be located ortho, meta or para relative to the phosphorous linkage.
  • each group Y represents a group - (X) a -Ph- [ (L) b -Z-CF 3 ] m above, where X, Ph, L, b, Z and m are each as defined above.
  • Z represents a linear group -(CF 2 ) n - where n represents 4, 5, 6 or 7.
  • n represents 4, 5, 6 or 7.
  • la represents 1 and q represents 3) .
  • the present invention provides a catalyst for use in the catalysis of hydroformylation of an alkene, said catalyst comprising a ligand of general formula I (where X, Ph, n and m are as defined above) .
  • the ligand of said catalyst is described by general formula la (where n and m are as defined above, but n preferably represents 4, 5, 6 or 7 and m preferably represents 3) .
  • the catalyst described above is used in the hydroformylation of higher alkenes, that is alkenes of C 6 or above.
  • alkenes that is alkenes of C 6 or above.
  • C ⁇ - C 20 alkenes for example C 9 - C 14 ) are of most commercial interest.
  • the catalyst can either be prepared in situ by addition of the phosphorous based ligand (of Formula I above) to a rhodium containing precursor.
  • the catalyst may be provided as a pre-formed complex between the phosphorous ligand and rhodium. In the latter case excess phosphorous ligand may be added.
  • the rhodium catalytic complex may have the formula:
  • L 1 is a ligand of formula I above and d is an integer of 1 to 6;
  • c is an integer of 1 or more, preferably 1 to 6 , most preferably c is 1 or 2;
  • L 2 , L 3 , L 4 and L 5 are each Iigands attached to the rhodium and may be the same or different.
  • L 2 , L 3 , L 4 and L 5 may each independently represent a ligand according to formula 1 above, a halide (Cl, Br, F) , a carboxylate, 3-diketonate, alkoxide, ketone, open chain or cyclic ether, water, alcohol, sulphoxide, sulphalone, amide, a sulphur donor (such as a thiol, thiolate, dialkyl sulphide, heterocycle containing S, dialkylsulphoxide, dithiocarbamate, dithiophosphonate, dithiophosphate, xanthate, dithiocarbonate) ; a nitrogen donor (such as an amine, amide, nitrogen containing heterocycle, imine, nitric oxide) ; a phosphorous donor (such as mono- or di-prim
  • Iigands L 2 , L 3 , L 4 and 5 are each, independently, an integer of from 0 to 6. Any of Iigands L 2 , L 3 , L 4 and 5 may be joined to each other by a suitable bridging group.
  • rhodium containing precursor refers to a catalytic complex as described above to which a phosphorous ligand of formula I is to be added.
  • the rhodium containing precursor may be of formula :
  • the ligand of formula I may displace an existing ligand attached to the rhodium centre.
  • the present invention provides a process for hydroformylation of alkenes in a fiuorous multiphase system, said process comprising the step of adding a catalyst including a ligand of general formula I to the reactants.
  • the present invention provides a process for hydroformylation of alkenes in a fiuorous multiphase system, said process comprising the step of adding a ligand of formula I above and a rhodium precursor (as described above) to produce a catalyst in situ.
  • the ligand is described by general formula la.
  • the process relates to hydroformylation of higher (eg C 6 and above) alkenes, for example C 6 - C 20 alkenes.
  • C 9 - C 14 alkenes are of most commercial interest .
  • the P:Rh ratio is 20:1 or lower, preferably 12:1 or lower, for example 6:1 or even as low as 3:1.
  • the process further includes the step of recovering the catalytic complex by separating the fiuorous phase from the phase containing the reaction products.
  • Examples 1-12 Hydroformylation of Hex-1-ene
  • the solvents, rhodium complex and phosphorous containing compound were introduced in the autoclave under argon. C ⁇ /H 2 (total pressure 13 bar) was introduced and the autoclave heated with stirring to the reaction temperature. Hexene was contained in an injection unit between the autoclave and the mass flow controller. Once the conditions in the autoclave had stabilised, the tap between the injector and the autoclave was opened and gas from the ballast vessel allowed to pass through the mass flow controller to inject the hexene into the autoclave and bring the pressure in the autoclave to 20 bar. Readings of the pressure in the ballast vessel and the autoclave were taken every 5 seconds for approximately 1 hour. A typical reaction profile is shown in Figure 1.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

There is provided a catalytic complex comprising a ligand complexed directly or indirectly via a phosphorous moiety to a rhodium centre. The catalytic complex offers improved catalysis of alkene hydroformylation, preferably C9-C14 alkene hydroformylation, in a fluorous multi-phase system. The ligand disclosed is of general formula (I): (where X, Ph, L, Z, Y, a, b and m are as defined in Claim 1). Preferred ligands are of general formula (Ia): -P-{O-Ph-[Z-CF3]m}q (where Ph is an optionally substituted phenyl group; Z is a C1-11 fluorocarbon group; m is 1 to 5 and q is 1 to 3).

Description

ALKENE HYDROFORMYLATION CATALYST
The invention concerns an improved process for the hydroformylation of alkenes .
Hydroformylation is a major industrial process that involves the reaction of carbon monoxide and hydrogen with an alkene to give an aldehyde. For most alkenes, two products are possible depending upon the regioselectivity of the addition reaction. The two products, linear (n) aldehyde and branched (i) aldehyde are generally obtained as a mixture but it is usually the linear product that is preferred for industrial applications.
R
Figure imgf000003_0001
+ R
CHO There are currently two major industrial processes for the hydroformylation of alkenes. One process involves the use of cobalt catalysts, requires high temperatures and pressures and gives low n:i ratios. It is generally used for the production of higher aldehydes and alcohols (chain length > 5) . The second major process involves the use of Rh/triphenylphosphine complexes. This process operates under mild conditions of temperature and pressure and provides high n:i ratios. It is generally used for hydroformylation of ethene and propene, but also for 2-propen-l-ol conversion to butanediol .
The two reactions referred to above are both carried out in the homogeneous phase (i.e. the catalyst, substrate and products are all dissolved in a common solvent) and this means that a process is required for the separation of products, solvent and catalyst. Distillation is generally used, but the thermal sensitivity of the rhodium based catalysts means that they cannot be separated from longer chain aldehyde products (>C4) . One way of circumventing this problem is to use a two phase system with the catalyst dissolved in water. Since the substrate and products are immiscible in water, separation can be effected in a simple manner. However, substrates with chain lengths of greater than 6 have such low solubility in water that the rate of the hydroformylation is too low for the aqueous process to be of commercial interest; and yet, it is just these substrates (C9-C14 aldehydes) that are of interest for the production of soaps and detergents. Consequently the C9-C14 aldehydes are currently manufactured using the older, less selective, more energy intensive cobalt based systems.
There is thus a requirement for a more selective, less energy intensive process for the formation of aldehydes which is also suitable for higher aldehydes.
Recently, a new approach to the problem of separating rhodium-based catalysts from reaction product has been suggested. This approach suggests the use a two phase system in which one of the phases is fluorinated and the other phase is organic. These phases are immiscible at room temperature but, by careful choice of the two solvents, can be made miscible at the reaction temperature. If the catalyst is designed to be soluble only in the fiuorous phase, the reaction can be carried out in the monophasic higher temperature regime. Cooling effects phase separation such that the catalysts remain in the fiuorous phase and the products are in the organic phase. Separation of the two phases can then be carried out and the fiuorous phase containing the catalyst recycled.
Desirable properties of such a system are that the reaction rate should be high (comparable to that with Rh/PPh3) , that the rhodium content of the organic phase at the end of the reaction should be negligible and that the n:i ratio should be high, preferably using only a small amount of phosphine relative to rhodium.
Horvath et al . describe the use of P (CH2CH2C6F13) 3 and [Rh(CO)2 (acetylacetonate) ] as catalyst precursors (see J. Am. Chem. Soc . 120: pages 3133-3143, 1998) . Good reaction rates and low solubilities of the rhodium complex in the organic phase were obtained but, even with a P:Rh ratio as high as 102:1, the maximum n:i ratio was merely 7.84. An advantage of the system of the invention described below is that high rates and selectivity can be obtained using much less phosphorous compound. EP-A-0, 633, 062 describes the use of [Rh(C02) (acetylacetonate) ] with either P [CH2CH2 (CF2) 5CF3] 3 or P[OCH2CH2 (CF2)7CF3]3 at a P:Rh ratio of 40:1.
The invention concerns new Iigands for use in the fiuorous biphasic hydroformylation of alkenes, which Iigands allow the reaction to occur at rates similar to those obtained using Rh/PPh3 in organic solvents, which show little leaching of rhodium into the organic phase and which can provide high n:i ratios at low P:Rh loading. The Iigands described herein also promote isomerisation of alkenes and can be used for the hydroformylation of internal alkenes giving significant amounts of n-aldehydes.
We have found that Iigands of general formula I when complexed to a rhodium centre are especially good at catalysis of alkene hydroformylation in a fiuorous multiphase system of the type described above.
Thus, the present invention provides a catalytic complex comprising a ligand of general formula I:
-P-(X)a-Ph- [(L)b-Z-CF3]m I I (Y)2
(where
X is 0, S, C=0, N-R or C (R) 2 (where each group R independently represents H, a C^ alkyl group or an aryl group) ;
Ph is an optionally substituted phenyl ring; each group L independently represents a
Figure imgf000007_0001
alkenyl group or other linker group;
each group Z represents a branched or linear fluorocarbon chain of up to 11 carbon atoms, preferably 3 to 9 carbon atoms ;
each group Y independently represents a group
-(X)a-Ph-[(L)b-Z-CF3]m
(where each of the groups X, Ph, Z and L, and each of the integers a, b and m are independently as defined above) or each group Y may represent a C1-C12 alkyl or aryl, which may optionally be substituted;
each a is 0 or 1;
each b is 0 or 1; and
each m is an integer of from 1 to 5,
wherein said ligand is complexed directly or indirectly via the phosphorous moiety to a rhodium centre, for use in catalysis of hydroformylation of alkenes in a fiuorous multiphase system.
By "fiuorous multiphase system" we mean a system including a liquid-liquid biphase where one phase is a fiuorous phase containing a fiuorous solvent (typically a fluorocarbon or a fluorohydrocarbon) . Suitable solvents include fluorodimethylcyclohexane, perfluoromethylcyclohexane, hexafluorobenzene, pentafluorobenzene and the like.
In one embodiment the ligand of general formula I comprises a single fluorocarbon tail linked to a phenyl ring which is otherwise unsubstituted (apart from its connection to group X or to the phosphorous moiety) .
Group Z may represent a linear group -(CF2)n- and n is an integer of from 3 to 11. Desirably integer n represents 3, 4, 5, 6, 7, 8 or 9. Generally Iigands where n represents 4, 5, 6 or 7 are most convenient.
The fluorocarbon tail (eg. -Z-CF3) is required to adjust the solubility of the ligand in the fiuorous phase. Thus, the exact number of fluorinated carbon atoms is not fixed, but may vary according to the reactants, solvents and other reaction conditions. If a single -Z-CF3 tail is present, it may be located ortho, meta or para relative to the phosphorous linkage.
In one preferred embodiment each group Y represents a group - (X) a-Ph- [ (L) b-Z-CF3] m above, where X, Ph, L, b, Z and m are each as defined above.
One preferred embodiment of the ligand of the present invention is shown below in general formula la.
-P-{0-Ph- [Z-CF3]m}q la
(where q represents 1, 2 or 3 , and Ph, Z and m are each as defined above for general formula I) . Preferably Z represents a linear group -(CF2)n- where n represents 4, 5, 6 or 7. Preferably in formula la m represents 1 and q represents 3) .
A protocol suitable for preparation of the Iigands of general formulae I and la is described in Bhattacharyya et al . , J. Chem. Soc . , Perkin Trans. 1, pages 3609-3612 (1997). Whilst Battacharyya et al . suggest that the Iigands synthesised may be of use in a fiuorous biphasic reaction, there is no suggestion that the ability of these Iigands would be suitable for catalysis of alkene hydroformylation, nor that the catalysis of that reaction would provide the improved results - especially with regard to higher alkenes - now reported.
In a further aspect the present invention provides a catalyst for use in the catalysis of hydroformylation of an alkene, said catalyst comprising a ligand of general formula I (where X, Ph, n and m are as defined above) .
In a preferred embodiment the ligand of said catalyst is described by general formula la (where n and m are as defined above, but n preferably represents 4, 5, 6 or 7 and m preferably represents 3) .
Desirably the catalyst described above is used in the hydroformylation of higher alkenes, that is alkenes of C6 or above. Generally Cβ - C20 alkenes (for example C9 - C14) are of most commercial interest.
The catalyst can either be prepared in situ by addition of the phosphorous based ligand (of Formula I above) to a rhodium containing precursor. Alternatively, the catalyst may be provided as a pre-formed complex between the phosphorous ligand and rhodium. In the latter case excess phosphorous ligand may be added. The rhodium catalytic complex may have the formula:
L^Rh^L^gL5,.
where L1 is a ligand of formula I above and d is an integer of 1 to 6;
c is an integer of 1 or more, preferably 1 to 6 , most preferably c is 1 or 2;
L2, L3, L4 and L5 are each Iigands attached to the rhodium and may be the same or different. L2, L3, L4 and L5 may each independently represent a ligand according to formula 1 above, a halide (Cl, Br, F) , a carboxylate, 3-diketonate, alkoxide, ketone, open chain or cyclic ether, water, alcohol, sulphoxide, sulphalone, amide, a sulphur donor (such as a thiol, thiolate, dialkyl sulphide, heterocycle containing S, dialkylsulphoxide, dithiocarbamate, dithiophosphonate, dithiophosphate, xanthate, dithiocarbonate) ; a nitrogen donor (such as an amine, amide, nitrogen containing heterocycle, imine, nitric oxide) ; a phosphorous donor (such as mono- or di-primary, secondary or tertiary phosphine, phosphite, phosphinite, phosphonite, phosphole or heterocycle containing phosphorous, phosphide, phosphoalkene, phosphoalkyene) ; arsenic donor (such as mono- or di-tertiary arsine or heterocycle containing arsenic) ; an antimony donor (such as stibine) ; a carbon donor (such as carbon monoxide, carbon dioxide, diene, triene or polyene, an alkyl or aryl goup, a carbene) ; a silicon donor (such as silyl or silylene group) ; and
e, f, g and h are each, independently, an integer of from 0 to 6. Any of Iigands L2, L3, L4 and 5 may be joined to each other by a suitable bridging group.
A reference to a "rhodium containing precursor" refers to a catalytic complex as described above to which a phosphorous ligand of formula I is to be added. The rhodium containing precursor may be of formula :
RhcL2 e 3 fL4 gL5 h
where c, e, f, and h are as defined above, but e+f+g+h=l or more; and L2, L3, L4 and L5 are as defined above .
Optionally, the ligand of formula I may displace an existing ligand attached to the rhodium centre.
In a further aspect the present invention provides a process for hydroformylation of alkenes in a fiuorous multiphase system, said process comprising the step of adding a catalyst including a ligand of general formula I to the reactants.
In an alternative embodiment the present invention provides a process for hydroformylation of alkenes in a fiuorous multiphase system, said process comprising the step of adding a ligand of formula I above and a rhodium precursor (as described above) to produce a catalyst in situ.
Desirably the ligand is described by general formula la.
Optionally, the process relates to hydroformylation of higher (eg C6 and above) alkenes, for example C6 - C20 alkenes. C9 - C14 alkenes are of most commercial interest .
In one embodiment the P:Rh ratio is 20:1 or lower, preferably 12:1 or lower, for example 6:1 or even as low as 3:1.
Optionally the process further includes the step of recovering the catalytic complex by separating the fiuorous phase from the phase containing the reaction products.
The present invention will now be described further with reference to the following, non-limiting, examples. (Examples 1 to 5 inclusive are comparative Examples.)
Examples
All reactions were carried out in a mechanically stirred Hastelloy C autoclave fitted with a ballast vessel from which gas was metered into the reaction autoclave via a mass-flow controller so as to maintain a constant pressure within the reaction autoclave. The rate of reaction was measured by monitoring the rate of pressure drop within the ballast vessel.
Examples 1-12: Hydroformylation of Hex-1-ene The solvents, rhodium complex and phosphorous containing compound were introduced in the autoclave under argon. Cθ/H2 (total pressure 13 bar) was introduced and the autoclave heated with stirring to the reaction temperature. Hexene was contained in an injection unit between the autoclave and the mass flow controller. Once the conditions in the autoclave had stabilised, the tap between the injector and the autoclave was opened and gas from the ballast vessel allowed to pass through the mass flow controller to inject the hexene into the autoclave and bring the pressure in the autoclave to 20 bar. Readings of the pressure in the ballast vessel and the autoclave were taken every 5 seconds for approximately 1 hour. A typical reaction profile is shown in Figure 1.
From the results in Table 1 it is clear that P(OC6H4-4-C6F13)3 and P (OC6H4-3-C6F13) 3 have considerable benefits over other Iigands studied with high reaction rates and good n:i ratio at a P:Rh ration of 3:1. Visual inspection of the resulting two phase mixture showed that the top (organic) phase was colourless whilst the lower (fiuorous) phase was yellow in colour. Analytical data on the rhodium content of the organic phase is currently being obtained.
The results, collected in Table 1, were obtained under the following conditions (unless otherwise stated) : [Rh(acac) (CO)2_ (0.01 mol dm"3), phosphine (0.03 mol dm"3) , hex-1-ene (1 cm3) in a mixture of toluene (2 cm3) and PP3 (2 cm3), 70'C, 20 bar, 1 hour.
t
Figure imgf000014_0002
lisom=isomerised hexenes, 2EtP=2-ethylpentanal, 2MeH=2-methylhexanal, H=heptanal, TOF=turnover frequency (moles of hex-1-ene consumed per mol of rhodium per second); n:i=ratio of straight to total branched aldehydes. a In toluene (4 cm3) ; b Zero order throughout most of the reaction; c [Rh(acac) (CO)2] (0.001 mol dm"3), P (OC6H4-4-C6F13) 3 (0.003 mol dm"3); d
Figure imgf000014_0001
Conditions (unless otherwise stated): [Rh(acac) (CO) 2] (0.01 mol dm"3), phosphine (0.03 mol dm"3), hex-1-ene (1 cm3) in a mixture of toluene (2 cm3) and PP3 (2 cm3), 70 °C, 20 bar, 1 hour.
Examples 13-16 : Hydroformylation of Nonenes
The procedure of Examples 1-12 was followed, using either 1-nonene or 2-nonene as substrate.
The results, collected in Table 2, were obtained under the following conditions (unless otherwise stated) : [Rh(acac) (CO)2] (0.01 mol dm"3), P (OC6H4-4-C6F13) 3 (0.03 mol dm"3) , nonene (1 cm3) in a mixture of toluene (2 cm3) and PP3 (2 cm3), 70*C, 20 bar, 1 hour.
TABLE 2. Hydroformylation of Nonenes
Figure imgf000016_0003
2PrH=2 propylhexanal, 2EtO=2-ethyloctanal, 3MeN=2-methylnonanal, D=decanal
Figure imgf000016_0001
a 1-nonene as substrate;
0x> b 2 -nonene as substrate;
otherwise stated): [Rh(acac) (CO) 2] (0.01 mol dm"3 P(C6H4-4-C3F13)3 (0.03 mol dm" 1 -nonene (1 f toluene (2 cm3) and PP3 (2 cm3), 70*C, 20 bar, 1 hour.
Figure imgf000016_0002

Claims

1. A catalytic complex comprising a ligand of general formula I :
-P-(X)a-Ph-[(L)b-Z-CF3]m I I (Y)2
(where
X is O, S, C=0, N-R or C (R) 2 (where each group R independently represents H, a Cx_s alkyl group or an aryl group) ;
Ph is an optionally substituted phenyl ring;
each group L independently represents a C _6 alkenyl group or other linker group;
each group Z represents a branched or linear fluorocarbon chain of up to 11 carbon atoms;
each group Y independently represents a group
-(X)a-Ph-[(L)b-Z-CF3]m
(where each of the groups X, Ph, Z and L, and each of the integers a, b and m are independently as defined above) or each group Y may represent a C1-C12 alkyl or aryl, which may optionally be substituted;
each a is 0 or 1;
each b is 0 or 1; and
each m is an integer of from 1 to 5, wherein said ligand is complexed directly or indirectly via the phosphorous moiety to a rhodium centre.
2. A complex as claimed in Claim 1 wherein in said ligand group Z represents a branched or linear fluorocarbon chain having 3 to 9 carbon atoms .
3. A complex as claimed in either one of Claims 1 and 2 wherein in said ligand group Ph is substituted by hydrogen only apart from its connection to group X or to the phosphorous moiety and its connection to a single fluorocarbon tail .
4. A complex as claimed in any one of Claims 1 to 3 wherein in said ligand group Z represents a linear group -(CF2)n-, where n is an integer of from 3 to 11.
5. A complex as claimed in Claim 4 wherein in said ligand n represents 4, 5, 6 or 7.
6. A complex as claimed in any one of Claims 1 to 5 wherein in said ligand each group Y represents a group - (X)a-Ph- [ (L)6-Z-CF3]ra-, where X, Ph, L, b, Z and m are each as defined in Claim 1.
7. A complex as claimed in any one of Claims 1 to 6 wherein said ligand is of general formula la,
-P-{0-Ph-[Z-CF3]m}q la
(where q represents 1, 2 or 3, and Ph, Z and m are each as defined in Claim 1) .
8. A complex as claimed in Claim 7 wherein in said ligand Z represents a linear group -(CF2)n- where n is 4, 5, 6 or 7.
9. A complex as claimed in either one of Claims 7 and 8 wherein in said ligand m is 1 and q is 3.
10. A complex as claimed in any one of Claims 1 to 9 wherein Iigands which are not of formula I are also attached to the rhodium centre.
11. Use of the complex as claimed in any one of Claims 1 to 10 in the catalysis of alkene hydroformylation in a fiuorous multiphase system.
12. The use as claimed in Claim 11 wherein the fiuorous multiphase system comprises a fiuorous solvent selected from fluorodimethylcyclohexane, perfluoromethylcyclohexane, hexafluorobenzene and pentafluorobenzene.
13. The use as claimed in either one of Claims 11 and 12 wherein said alkene has six or more carbon atoms.
14. The use as claimed in Claim 13 wherein said alkene has from nine to fourteen carbon atoms.
15. A process for the hydroformylation of alkenes in a fiuorous multi-phase system, said process comprising the step of adding a catalyst to the reactants, wherein said catalyst is a complex as claimed in any one of Claims 1 to 10.
16. The process as claimed -in Claim 15 wherein said ligand is as defined in any one of Claims 7 to 9.
17. The process as claimed in either of Claims 15 and 16 for the hydroformylation of alkenes having six or more carbon atoms.
18. The process as claimed in Claim 17 for the hydroformylation of C9-C14 alkenes.
19. The process as claimed in any one of Claims 15 to 18 wherein said catalyst has a P:Rh ratio of 20:1 or lower.
20. The process as claimed in Claim 19 wherein said catalyst has a P:Rh ratio of 12:1 or lower.
21. The process as claimed in any one of Claims 15 to 20 which further includes the step of recovering the catalyst by separating the fiuorous phase from the phase containing the reaction products.
22. A process for the hydroformylation of alkenes in a fiuorous multi-phase system, said process comprising the step of adding a rhodium containing precursor and a ligand to the reactants to produce a catalytic complex as claimed in any one of Claims 1 to 10 in situ.
23. The process as claimed in Claim 22 wherein said ligand is as defined in any one of Claims 7 to 9.
24. The process as claimed in either of Claims 22 and 23 for the hydroformylation of alkenes having six or more carbon atoms.
25. The process as claimed in Claim 24 for the hydroformylation of C9-C14 alkenes.
26. The process as claimed in any one of Claims 22 to 25 wherein said catalyst has a P:Rh ratio of 20:1 or lower.
27. The process as claimed in Claim 26 wherein said catalyst has a P:Rh ratio of 12:1 or lower.
28. The process as claimed in any one of Claims 22 to 27 which further includes the step of recovering the catalyst by separating the fiuorous phase from the phase containing the reaction products.
PCT/GB1999/004062 1998-12-04 1999-12-03 Alkene hydroformylation catalyst Ceased WO2000033956A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU15744/00A AU1574400A (en) 1998-12-04 1999-12-03 Alkene hydroformylation catalyst

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9826619.0A GB9826619D0 (en) 1998-12-04 1998-12-04 Catalyst
GB9826619.0 1998-12-04
GBGB9902338.4A GB9902338D0 (en) 1999-02-03 1999-02-03 Catalyst
GB9902338.4 1999-02-03

Publications (1)

Publication Number Publication Date
WO2000033956A1 true WO2000033956A1 (en) 2000-06-15

Family

ID=26314783

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/004062 Ceased WO2000033956A1 (en) 1998-12-04 1999-12-03 Alkene hydroformylation catalyst

Country Status (2)

Country Link
AU (1) AU1574400A (en)
WO (1) WO2000033956A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495497B1 (en) * 2001-09-26 2002-12-17 International Flavors & Fragrances Inc. Use of 4-ethyloctanal in perfume compositions
US6495186B1 (en) * 2001-09-26 2002-12-17 International Flavors & Fragrances Inc. Use of 4-ethyloctanal in perfume and flavor compositions
US7404943B2 (en) 2001-05-30 2008-07-29 The Regents Of The University Of California Methods for solubilizing and recovering fluorinated compounds
US10625249B2 (en) 2016-04-14 2020-04-21 Technische Universität Berlin Catalyst for the hydroformylation of olefins, and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633062A1 (en) * 1993-07-08 1995-01-11 Exxon Research And Engineering Company Fluorous multiphase catalyst or reagent systems, and processes using them
DE19702025A1 (en) * 1997-01-23 1998-07-30 Studiengesellschaft Kohle Mbh Use of perfluoroalkyl-substituted phosphorus compounds as ligands for homogeneous catalysis in supercritical carbon dioxide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633062A1 (en) * 1993-07-08 1995-01-11 Exxon Research And Engineering Company Fluorous multiphase catalyst or reagent systems, and processes using them
DE19702025A1 (en) * 1997-01-23 1998-07-30 Studiengesellschaft Kohle Mbh Use of perfluoroalkyl-substituted phosphorus compounds as ligands for homogeneous catalysis in supercritical carbon dioxide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
P. BHATTACHARYYA ET AL.: "Phosphorus(III) ligands with fluorous ponytails", JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1., 1997, CHEMICAL SOCIETY. LETCHWORTH., GB, pages 3609 - 3612, XP002131617, ISSN: 0300-922X *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404943B2 (en) 2001-05-30 2008-07-29 The Regents Of The University Of California Methods for solubilizing and recovering fluorinated compounds
US6495497B1 (en) * 2001-09-26 2002-12-17 International Flavors & Fragrances Inc. Use of 4-ethyloctanal in perfume compositions
US6495186B1 (en) * 2001-09-26 2002-12-17 International Flavors & Fragrances Inc. Use of 4-ethyloctanal in perfume and flavor compositions
US10625249B2 (en) 2016-04-14 2020-04-21 Technische Universität Berlin Catalyst for the hydroformylation of olefins, and use thereof

Also Published As

Publication number Publication date
AU1574400A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
JP3051986B2 (en) Carbonylation catalyst
JPH02277550A (en) Carbonylation catalyst system
CN101909752A (en) Fluorinated phosphite catalysts for hydroformylation processes
EP1519904B1 (en) Phosphorus containing ligands for metathesis catalysts
JPH09221443A (en) Hydroformylation of olefin compound
JP3009635B2 (en) Catalyst system based on rhodium complex containing diphosphine ligand and method for producing aldehyde using the same
US20050215829A1 (en) Process for the synthesis of alpha-substituted acroleins
CA2256991A1 (en) Process for preparing aldehydes
US6103908A (en) Nonaqueous ionic ligand liquids, process for preparing them and their use as catalyst constituents
JP2014169346A (en) Mixed solution of transition metal complex with aromatic phosphite
US20100010270A1 (en) Hydroformylation method involving a cobalt-based catatlyst in a non-aqueous ionic liquid
WO2000033956A1 (en) Alkene hydroformylation catalyst
EP1473297B1 (en) Process for producing tertiary phosphine having bulky hydrocarbon group bonded
US6613939B2 (en) Purified sulfonated organophosphorus compounds and catalysis of organic reactions therewith
EP0158518A2 (en) Process and accompanying catalysts for the hydroformylation of formaldehyde to glycol aldehyde
CN101909753A (en) Phosphonite-containing catalysts for hydroformylation processes
US6339174B1 (en) Method for preparing aldehydes by hydroformylation
JP3846020B2 (en) Bisphosphite compound and method for producing aldehydes using the compound
US7002044B2 (en) Catalysis by water-soluble organometallic complexes in water-in-densified fluid microemulsions
US6806391B2 (en) Process for the carbonylation of ethylenically unsaturated compounds and bidentate diphosphine composition used in this process
US6509505B1 (en) Phosphabenzene compounds and their use in hydroformylation
KR930002361B1 (en) Process for producing aldehydes or mixtures of ketones and aldehydes
KR20040095305A (en) Bisphosphine, process for producing the same, and use thereof
US6114588A (en) Hydroformylation of alpha-alcohol-diolefins to dialcohols
EP0130085A1 (en) Process for the production of glycol aldehyde and catalyst therefor

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 15744

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase